Short answer · Medically reviewed summary · Last updated: 2026-05-08
CDKL5 deficiency disorder (CDD) is a rare genetic condition typically diagnosed in infancy through genetic testing after the onset of early-life seizures and significant developmental delays. There is no "self-assessment" for CDKL5; if you suspect a child is exhibiting these signs, a clinical evaluation by a pediatric neurologist and geneticist is required to confirm the diagnosis. What are the early signs of CDKL5 deficiency disorder? CDKL5 deficiency disorder usually manifests within the first few months of life.
2 people with CDKL5 have shared their first-person experience on this question at DiseaseMaps.
How do I know if I have CDKL5?
Could you have CDKL5? Early signs that prompted real patients to seek diagnosis, plus medically reviewed guidance.
CDKL5 deficiency disorder (CDD) is a rare genetic condition typically diagnosed in infancy through genetic testing after the onset of early-life seizures and significant developmental delays. There is no "self-assessment" for CDKL5; if you suspect a child is exhibiting these signs, a clinical evaluation by a pediatric neurologist and geneticist is required to confirm the diagnosis.
What are the early signs of CDKL5 deficiency disorder?
CDKL5 deficiency disorder usually manifests within the first few months of life. The hallmark symptom is the onset of refractory epilepsy—seizures that are difficult to control with standard medications. Parents often notice that their child struggles with severe developmental delays, including difficulty reaching milestones like sitting, crawling, or purposeful hand use.
How is CDKL5 diagnosed?
Diagnosis is confirmed through a genetic blood test. Because CDKL5 is an X-linked condition, geneticists look for pathogenic variants in the CDKL5 gene. Clinical evaluation involves:
- Review of seizure semiology (how seizures present).
- Comprehensive neurodevelopmental assessment.
- Targeted genetic panels or Whole Exome Sequencing (WES).
When should I seek urgent medical evaluation?
If an infant experiences new-onset seizures, especially if accompanied by developmental regression or lack of eye contact, you should seek immediate evaluation from a pediatric neurologist. While CDKL5 is rare, early intervention is critical for managing seizure burden and providing supportive therapies.
How do I advocate for a genetic evaluation?
If your concerns are dismissed, bring a symptom log to your physician. Clearly state: "I am concerned about early-onset seizures and global developmental delay; I would like a referral to a geneticist to discuss CDKL5 testing." You are your own best advocate; if you feel unheard, seek a second opinion at a major academic medical center or a center specializing in rare pediatric epilepsy.
Next steps
- Consult a pediatric neurologist for a formal seizure evaluation.
- Request a referral to a genetic counselor to discuss CDKL5 testing.
- Connect with the 71 members of our CDKL5 community at DiseaseMaps.org to learn from shared experiences.
- Visit the International Foundation for CDKL5 Research for clinical trial information.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): CDKL5 deficiency disorder.
- Orphanet: CDKL5 deficiency disorder (ORPHA:101016).
- OMIM (Online Mendelian Inheritance in Man): CDKL5 gene entry (#300672).
- International Foundation for CDKL5 Research (IFCR).
Posted May 23, 2017 by Beth Ann 2120
Posted Oct 3, 2017 by Mònica de la Torre 800
